You have 9 free searches left this month | for more free features.

Nandrolone

Showing 1 - 25 of 29

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Sarcopenia Trial in Warsaw (Nandrolone Decanoate, Physiotherapy Intervention, Nutritional Intervention)

Recruiting
  • Sarcopenia
  • Nandrolone Decanoate
  • +3 more
  • Warsaw, Mazowieckie, Poland
    Centrum Wsparcia Badań Klinicznych
Jul 28, 2023

Arrest, Bone, Development Trial in Lahore (Propranolol, Nandrolone Decanoate)

Recruiting
  • Arrest
  • +3 more
  • Lahore, Punjab, Pakistan
    King Edward Medical University, Mayo Hospital
Mar 27, 2023

HIV, HIV Wasting Syndrome Trial in Puerto Rico, United States (Nandrolone decanoate)

Completed
  • HIV Infections
  • HIV Wasting Syndrome
  • Nandrolone decanoate
  • Los Angeles, California
  • +21 more
Oct 27, 2021

Hip Fractures Trial in Hvidovre (drug, dietary supplement, other)

Completed
  • Hip Fractures
  • Nandrolone Decanoate
  • +3 more
  • Hvidovre, Denmark
    Hvidovre Hospital
Feb 9, 2021

Burns Trial in Galveston (procedure, drug, behavioral)

Terminated
  • Burns
  • Stable Isotope Infusion Study
  • +11 more
  • Galveston, Texas
    University of Texas Medical Branch
Nov 26, 2019

Cachexia; Cancer Trial in Curitiba (Nandrolone Decanoate, Dexamethasone)

Completed
  • Cachexia; Cancer
  • Curitiba, Paraná, Brazil
    Hospital Erasto Gaertner
Feb 25, 2019

Burns Trial in Galveston (Stable Isotope Infusion study, Insulin High Dose, oxandrolone)

Completed
  • Burns
  • Stable Isotope Infusion study
  • +10 more
  • Galveston, Texas
    University of Texas Medical Branch
Nov 26, 2019

Polytrauma Trial in Ostrava (Vitamin D3 + anabolic substance, No Vitamin D3 + anabolic substance)

Completed
  • Polytrauma
  • Vitamin D3 + anabolic substance
  • No Vitamin D3 + anabolic substance
  • Ostrava, Moravian-Silesian Region, Czechia
    University Hospital Ostrava
Dec 6, 2022

Bioequivalence Trial in Chennai (Estradiol Valerate and Dienogest 2 mg/ 2 mg Test Drug tablet, Estradiol Valerate and Dienogest

Completed
  • Bioequivalence
  • Estradiol Valerate and Dienogest 2 mg/ 2 mg Test Drug tablet
  • Estradiol Valerate and Dienogest 2 mg/ 2 mg Reference Product tablet
  • Chennai, Tamil Nadu, India
    Azidus Laboratories Ltd.
Apr 11, 2022

Muscle Atrophy Trial in Maastricht (behavioral, drug, dietary supplement)

Completed
  • Muscle Atrophy
  • Inactivity
  • +2 more
  • Maastricht, Limburg, Netherlands
    Maastricht University Medical Centre+
Aug 28, 2017

Bioequivalence Trial in Santiago (Dienogest 2.0 mg Test Drug, Dienogest 2.0 mg Reference Product)

Completed
  • Bioequivalence
  • Dienogest 2.0 mg Test Drug
  • Dienogest 2.0 mg Reference Product
  • Santiago, Chile
    Innolab
Jan 13, 2020

Focus: Bioequivalence Trial in Erfurt (Dienogest-Ethinyl Estradiol (test product), Dienogest-Ethinyl Estradiol (reference

Completed
  • Focus: Bioequivalence
  • Dienogest-Ethinyl Estradiol (test product)
  • Dienogest-Ethinyl Estradiol (reference product)
  • Erfurt, Thüringen, Germany
    SocraTec R&D
Mar 4, 2020

Bioequivalence Trial in Santiago (Dienogest 2.0 mg and Ethinyl estradiol 0.03 mg Test Drug, Dienogest 2.0 mg and Ethinyl

Completed
  • Bioequivalence
  • Dienogest 2.0 mg and Ethinyl estradiol 0.03 mg Test Drug
  • Dienogest 2.0 mg and Ethinyl estradiol 0.03 mg Reference Product
  • Santiago, Chile
    Innolab
Dec 9, 2019

Healthy Men, Male Contraception Trial in Torrance, Seattle (Placebo, 11ßmethyl nortestosterone dodecylcarbonate)

Unknown status
  • Healthy Men
  • Male Contraception
  • Placebo
  • 11βmethyl nortestosterone dodecylcarbonate
  • Torrance, California
  • +1 more
Aug 9, 2019

Ovarian Reserve Trial in Istanbul (Estradiol valerate/dienogest)

Unknown status
  • Ovarian Reserve
  • Estradiol valerate/dienogest
  • İstanbul, Bagcilar, Turkey
    Tolga Karacan
Dec 27, 2018

Hypermetabolism in ICU, Loss of Muscle Mass, Functional Disability After ICU Trial in Clermont-Ferrand (AndroGel 16.2 mg/L)

Unknown status
  • Hypermetabolism in ICU
  • +4 more
  • AndroGel 16.2 mg/L
  • Clermont-Ferrand, France
    Chu Clermont-Ferrand
Feb 1, 2019

HIV Associate Weight Loss Trial in Los Angeles (Testosterone enanthate, Placebo)

Completed
  • HIV Associate Weight Loss
  • Testosterone enanthate
  • Placebo
  • Los Angeles, California
    Charles R. Drew University
Mar 7, 2018

Aplastic Anemia, Bone Marrow Failure Syndromes, Idiopathic Pulmonary Fibrosis Trial in Ribeirao Preto (Nandrolone Decanoate)

Unknown status
  • Aplastic Anemia
  • +3 more
  • Nandrolone Decanoate
  • Ribeirao Preto, Sao Paulo, Brazil
    Ribeirao Preto School of Medicine, University of Sao Paulo
Dec 1, 2015

Skin Aging, Quality of Life Trial in Sainte-Foy (Dehydroepiandrosterone, Placebos)

Completed
  • Skin Aging
  • Quality of Life
  • Sainte-Foy, Quebec, Canada
    Clinique des Traitements Hormonaux- CHUL Research Center
Apr 6, 2017

Pharmacology, Clinical Trial in Neu-Ulm (BAY 98-7079, Estradiolvalerate (EV) / Dienogest (DNG) / Levomefolate calcium, BAY

Completed
  • Pharmacology, Clinical
  • BAY 98-7079, Estradiolvalerate (EV) / Dienogest (DNG) / Levomefolate calcium
  • +2 more
  • Neu-Ulm, Bayern, Germany
    (unnamed)
Jul 29, 2016

Atrial Fibrillation Trial in São Paulo (Marevan®, generic warfarin #1, generic warfarin #2)

Completed
  • Atrial Fibrillation
  • São Paulo, Brazil
    Hospital São Paulo/Hospital Universitário da UNIFESP (University
Nov 21, 2016

Pharmacodynamics Trial in Groningen (Dienogest (81150037), Dienogest (81150231), Dienogest (SH T00660A))

Completed
  • Pharmacodynamics
  • Dienogest (81150037)
  • +3 more
  • Groningen, Netherlands
    (unnamed)
Jan 26, 2015

Anemia, Aplastic, Hematologic Diseases, Pancytopenia Trial (antilymphocyte serum, nandrolone)

Completed
  • Anemia, Aplastic
  • +3 more
  • antilymphocyte serum
  • nandrolone
  • (no location specified)
Nov 25, 2013

Malnutrition, Critical Illness Trial in London (Nandrolone (anabolic steroid), Placebo)

Terminated
  • Malnutrition
  • Critical Illness
  • Nandrolone (anabolic steroid)
  • Placebo
  • London, Ontario, Canada
    London Health Sciences Centre-UC
Jan 4, 2011